Acorah Software Products - Accounts Production 16.0.110 false true 31 October 2023 1 November 2022 false true No description of principal activity 1 November 2023 31 October 2024 31 October 2024 13677171 Sohil Ayub iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 13677171 2023-10-31 13677171 2024-10-31 13677171 2023-11-01 2024-10-31 13677171 frs-core:CurrentFinancialInstruments 2024-10-31 13677171 frs-bus:PrivateLimitedCompanyLtd 2023-11-01 2024-10-31 13677171 frs-bus:FilletedAccounts 2023-11-01 2024-10-31 13677171 frs-bus:Micro-entities 2023-11-01 2024-10-31 13677171 frs-bus:AuditExemptWithAccountantsReport 2023-11-01 2024-10-31 13677171 frs-bus:Director1 2023-11-01 2024-10-31 13677171 2022-10-31 13677171 2023-10-31 13677171 2022-11-01 2023-10-31 13677171 frs-core:CurrentFinancialInstruments 2023-10-31
Pharmsayub Ltd
Unaudited Financial Statements
For The Year Ended 31 October 2024
Accountant's Report
Chartered Accountant's report to the director on the preparation of the unaudited statutory accounts of Pharmsayub Ltd for the year ended 31 October 2024
In order to assist you to fulfil your duties under the Companies Act 2006, I have prepared for your approval the accounts of Pharmsayub Ltd for the year ended 31 October 2024 which comprise the Profit and Loss Account, the Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given to us.
As a practising member of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com/en/membership/regulations-standards-and-guidance.
This report is made solely to the director of Pharmsayub Ltd , as a body, in accordance with the terms of our latest engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of Pharmsayub Ltd and state those matters that we have agreed to state to the director of Pharmsayub Ltd , as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Pharmsayub Ltd and its director, as a body, for our work or for this report.
It is your duty to ensure that Pharmsayub Ltd has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit or loss of Pharmsayub Ltd . You consider that Pharmsayub Ltd is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit of the accounts of Pharmsayub Ltd . For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the financial statements.
Signed
02/12/2024
Dumaxa Accountancy Ltd
ICAEW
Page 1
Balance Sheet
Registered number: 13677171
2024 2023
£ £
Fixed assets 246 300
Current assets 95,727 60,785
Creditors: Amounts Falling Due Within One Year (37,648 ) (37,742 )
NET CURRENT ASSETS 58,079 23,043
TOTAL ASSETS LESS CURRENT LIABILITIES 58,325 23,343
NET ASSETS 58,325 23,343
CAPITAL AND RESERVES 58,325 23,343

Notes

1. General Information
Pharmsayub Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 13677171 . The registered office is 3 Mount Close, High Wycombe, Buckinghamshire, HP12 3PE.
2. Average Number of Employees
1Average number of employees, including directors, during the year was: 1 (2023: 1)
1 1
For the year ending 31 October 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Sohil Ayub
Director
02/12/2024